How big is the Pipette Controllers Market?

The Pipette Controllers Market size is expected to reach USD 210.40 million in 2024 and grow at a CAGR of 3.07% to reach USD 244.82 million by 2029. Read More

What is the current Pipette Controllers Market size?

In 2024, the Pipette Controllers Market size is expected to reach USD 210.40 million. Read More

Who are the key players in Pipette Controllers Market?

Gilson international, Merck KGaA, Avantor, Inc (VWR International, LLC), Sartorius AG and Bio-Rad Laboratories, Inc are the major companies operating in the Pipette Controllers Market. Read More

Which is the fastest growing region in Pipette Controllers Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Pipette Controllers Market?

In 2024, the North America accounts for the largest market share in Pipette Controllers Market. Read More

What years does this Pipette Controllers Market cover, and what was the market size in 2023?

In 2023, the Pipette Controllers Market size was estimated at USD 203.94 million. The report covers the Pipette Controllers Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Pipette Controllers Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Pipette Controllers Market Share

Statistics for the 2023 & 2024 Pipette Controllers market share, created by Mordor Intelligence™ Industry Reports. Pipette Controllers share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Pipette Controllers Industry

The pipette controllers market is competitive and consists of a number of major players. Some of the major players in the market include Sartorius AG, Bio-Rad Laboratories Inc., Avantor Inc. (VWR International LLC), Gilson International, and Merck KGaA. The market players focus on introducing new products to meet the evolving needs of the pharmaceutical and biotechnology industries.